Literature DB >> 17592732

Suppression of HIV replication using RNA interference against HIV-1 integrase.

Tat San Lau1, Yonggang Li, Masanori Kameoka, Tzi Bun Ng, David Chi Cheong Wan.   

Abstract

RNA interference (RNAi) has become one of the most powerful and popular approach on gene silencing in clinical research study especially in virology due to the gene-specific suppression property of small interfering RNA (siRNA). In this report, we demonstrate that expression of vector-mediated small hairpin RNA (shRNA) against human immunodeficiency virus type 1 (HIV-1) integrase (IN), one of the three important enzymes in HIV infection by controlling the integration of viral RNA to host DNA, could suppress the protein synthesis of EGFP-tagged IN in HeLa cell model efficiently. Furthermore, we show that IN shRNA can successfully reduce the HIV particles production in 293T cells at the level similar to the positive control of HIV-1 tat shRNA. These results provide the therapeutic possibility of HIV replication using RNAi against HIV-1 integrase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17592732     DOI: 10.1016/j.febslet.2007.06.011

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  RNA interference inhibits yellow fever virus replication in vitro and in vivo.

Authors:  Carolina C Pacca; Adriana A Severino; Adriano Mondini; Paula Rahal; Solange G P D'avila; José Antonio Cordeiro; Mara Correa Lelles Nogueira; Roberta V M Bronzoni; Maurício L Nogueira
Journal:  Virus Genes       Date:  2009-01-25       Impact factor: 2.332

2.  cRGD grafted siRNA nano-constructs for chemosensitization of gemcitabine hydrochloride in lung cancer treatment.

Authors:  Nirav Khatri; Mohan Rathi; Dipesh Baradia; Ambikanandan Misra
Journal:  Pharm Res       Date:  2014-05-03       Impact factor: 4.200

3.  Plasmids Expressing shRNAs Specific to the Nucleocapsid Gene Inhibit the Replication of Porcine Deltacoronavirus In Vivo.

Authors:  Jun Gu; Hao Li; Zhen Bi; Kai Li; Zhiquan Li; Deping Song; Zhen Ding; Houjun He; Qiong Wu; Dongyan Huang; Ping Gan; Yu Ye; Yuxin Tang
Journal:  Animals (Basel)       Date:  2021-04-23       Impact factor: 2.752

4.  HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF-κB pathway and can be silenced by gp120-specific siRNA.

Authors:  Ankit Shah; Anil Kumar
Journal:  J Neuroinflammation       Date:  2010-12-29       Impact factor: 8.322

5.  RNA interference approaches for treatment of HIV-1 infection.

Authors:  Maggie L Bobbin; John C Burnett; John J Rossi
Journal:  Genome Med       Date:  2015-05-28       Impact factor: 11.117

Review 6.  Prospects for Foamy Viral Vector Anti-HIV Gene Therapy.

Authors:  Arun K Nalla; Grant D Trobridge
Journal:  Biomedicines       Date:  2016-03-29

Review 7.  The therapeutic landscape of HIV-1 via genome editing.

Authors:  Alexander Kwarteng; Samuel Terkper Ahuno; Godwin Kwakye-Nuako
Journal:  AIDS Res Ther       Date:  2017-07-14       Impact factor: 2.250

8.  Significant inhibition of re-emerged and emerging swine enteric coronavirus in vitro using the multiple shRNA expression vector.

Authors:  Kai Li; Hao Li; Zhen Bi; Deping Song; Fanfan Zhang; Dan Lei; Suxian Luo; Zhiquan Li; Wang Gong; Dongyan Huang; Yu Ye; Yuxin Tang
Journal:  Antiviral Res       Date:  2019-03-21       Impact factor: 5.970

9.  A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery.

Authors:  James J Lu; Robert Langer; Jianzhu Chen
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.